ÂÜÀòÂÒÂ×

Reimar Schlingensiepen has over 20 years of experience in the pharmaceutical, biotechnological, and medical device industries. Reimar began their career in 1996 as the Head of Marketing and Product Development at Biognostik Molecular Diagnostics GmbH. Reimar then moved to Isarna Therapeutics GmbH in 1999 as COO and CFO. In 2008, they took on the role of BD and Interim Management at cerboMed GmbH, and then Interim Management and BD at JADO Technologies GmbH. From 2008-2015 they were the CEO of Themeos Interim Management and Business Development, and in 2015 they took on the roles of CEO and COO at AudioCure Pharma GmbH. In 2013, they became a m4-award Coach at the University of Wuerzburg, and in 2012 they became a GoBio Coach at SmartmAb University of Wuerzburg. In 2018, they began their current role as Head of BD & Strategy at Pentracor GmbH, where they focus on business development and interim management, as well as optimizing processes to make the company more attractive for investors and licensors.

Reimar Schlingensiepen studied Medicine at the University of Oxford from 1988 to 1989. Reimar then studied at Pierre and Marie Curie University from 1990 to 1991. Reimar completed their Doctor of Philosophy (Ph.D.) in Medizin at The University of Göttingen.